DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Morphine (Morphine) - Constipation - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Constipation (30)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Morphine where reactions include constipation. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 30   Next >>

Possible Morphine side effects in 52 year old male

Reported by a consumer/non-health professional from United States on 2012-07-20

Patient: 52 year old male

Reactions: Abdominal Hernia, Abdominal Pain, Weight Decreased, Vomiting, Dyspnoea, Abdominal Hernia Obstructive, Retching, Nausea, Constipation, Loss of Consciousness, Abdominal Infection, Malaise, Chest Pain, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Morphine Sulfate
    Dosage: 30 mg, 2 bid, oral
    Administration route: Oral
    Indication: Pain
    Start date: 2007-01-01

Morphine
    Dosage: oral
    Administration route: Oral
    Indication: Pain
    Start date: 2007-01-01



Possible Morphine side effects in 58 year old male

Reported by a pharmacist from United States on 2012-07-17

Patient: 58 year old male

Reactions: Drug Effect Decreased, Drug Effect Delayed, Constipation

Drug(s) suspected as cause:
Morphine
    Indication: Pain

Morphine
    Dosage: 15 mg q 9hrs
    Administration route: Oral
    Indication: Intervertebral Disc Protrusion
    Start date: 2011-09-01
    End date: 2011-09-04

Other drugs received by patient: Lidocaine; Morphine Sulfate; Vicodin; Aspirin; Miralax; Celebrex



Possible Morphine side effects in male

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-07-06

Patient: male, weighing 83.0 kg (182.6 pounds)

Reactions: Gastrointestinal Haemorrhage, Peptic Ulcer, Constipation, Faeces Discoloured, Abdominal Discomfort, Dizziness, Abdominal Distension, Epistaxis

Drug(s) suspected as cause:
Ultracet
    Administration route: Oral
    Indication: Postoperative Analgesia
    Start date: 2010-03-04

Morphine
    Indication: Postoperative Analgesia
    Start date: 2010-03-04

Diclofenac Sodium
    Indication: Postoperative Analgesia
    Start date: 2010-03-04



Possible Morphine side effects in male

Reported by a physician from Sweden on 2012-06-14

Patient: male

Reactions: Weight Decreased, Nausea, Constipation, Faecaloma

Drug(s) suspected as cause:
Morphine Sulfate
    Dosage: 20 mg, daily
    Administration route: Oral
    Indication: Malignant Neoplasm of Thorax
    Start date: 2012-03-21
    End date: 2012-04-08

Morphine
    Dosage: 5 mg, prn
    Indication: Malignant Neoplasm of Thorax
    Start date: 2012-03-21
    End date: 2012-04-19

Other drugs received by patient: Duragesic-100; Enalapril Maleate; Alvedon; Glipizide; Betolvidon



Possible Morphine side effects in 64 year old female

Reported by a consumer/non-health professional from Brazil on 2012-06-05

Patient: 64 year old female, weighing 65.0 kg (143.0 pounds)

Reactions: Abdominal Pain, Weight Decreased, Spinal Pain, Malaise, Nasal Dryness, Convulsion, Tremor, Eating Disorder, Dysphonia, Bedridden, Buccal Mucosal Roughening, Drug Ineffective, Pain, Tumour Pain, Neoplasm Progression, Constipation, Drug Abuse, Somnolence, Disease Progression, Feeling Cold, Abdominal Pain Upper, Liver Disorder, Fatigue, Skin Discolouration, Metastatic Renal Cell Carcinoma, Decreased Appetite, Blood Pressure Increased, Aphthous Stomatitis, Dyspnoea, Nail Discolouration, Nausea, Muscular Weakness, Ageusia, Blood Pressure Fluctuation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Acetaminophen
    Dosage: unk
    Indication: Pain

Buscopan Plus
    Dosage: unk
    Indication: Pain

Sutent
    Dosage: 50 mg, 1x/day, 4 weeks on/2 weeks off
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2012-01-26
    End date: 2012-05-23

Sutent
    Indication: Metastases To Spine

Acetaminophen W / Codeine
    Dosage: unk
    Indication: Pain

Morphine
    Dosage: a half of one tablet every 4 hours
    Indication: Pain

Morphine
    Dosage: one tablet every 4 hours

Sutent
    Indication: Renal Cell Carcinoma

Other drugs received by patient: Phenytoin; Nystatin; Vitamin E; Omeprazole; Digesan; Rifaldin; Scopolamine; Buscopan Comp.; Luftal



Possible Morphine side effects in male

Reported by a health professional (non-physician/pharmacist) from South Africa on 2012-06-04

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: Abdominal Pain, Vomiting, Neoplasm Malignant, Nausea, Hypophagia, Intestinal Obstruction, Pyrexia, Constipation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tasigna
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2010-11-19
    End date: 2011-04-11

Tasigna
    Dosage: 400 mg, qd

Tasigna
    Dosage: 400 mg, bid
    Administration route: Oral
    End date: 2010-11-01

Lentogesic
    Dosage: unk
    Administration route: Oral
    Indication: Pain
    Start date: 2010-10-12
    End date: 2010-10-26

Duragesic-100
    Dosage: unk

Imatinib Mesylate
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Gastrointestinal Stromal Tumour
    Start date: 2011-04-16
    End date: 2011-04-17

Morphine
    Dosage: unk

Zafor
    Dosage: 400 mg, prn
    Administration route: Oral
    Indication: Nausea
    Start date: 2010-10-17
    End date: 2010-10-26

Tasigna
    Dosage: 400 mg, bid
    Administration route: Oral
    Indication: Gastrointestinal Stromal Tumour
    Start date: 2010-10-13
    End date: 2010-10-14

Imatinib Mesylate
    Dosage: 400 mg, daily
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-11-02

Other drugs received by patient: Omeprazole; Iron Supplements; Calcium; Sucralfate; Rabeprazole Sodium



Possible Morphine side effects in male

Reported by a physician from South Africa on 2012-06-01

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: Abdominal Pain, Vomiting, Neoplasm Malignant, Nausea, Hypophagia, Intestinal Obstruction, Pyrexia, Constipation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tasigna
    Dosage: 400 mg, qd

Morphine
    Dosage: unk

Zafor
    Dosage: 400 mg, prn
    Administration route: Oral
    Indication: Nausea
    Start date: 2010-10-17
    End date: 2010-10-26

Tasigna
    Dosage: 400 mg, bid
    Administration route: Oral
    End date: 2010-11-01

Tasigna
    Dosage: 400 mg, bid
    Administration route: Oral
    Indication: Gastrointestinal Stromal Tumour
    Start date: 2010-10-13
    End date: 2010-10-14

Imatinib Mesylate
    Dosage: 400 mg, daily
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-11-02

Tasigna
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2010-11-19
    End date: 2011-04-11

Lentogesic
    Dosage: unk
    Administration route: Oral
    Indication: Pain
    Start date: 2010-10-12
    End date: 2010-10-26

Imatinib Mesylate
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Gastrointestinal Stromal Tumour
    Start date: 2011-04-16
    End date: 2011-04-17

Duragesic-100
    Dosage: unk

Other drugs received by patient: Sucralfate; Rabeprazole Sodium; Iron Supplements; Omeprazole; Calcium



Possible Morphine side effects in 62 year old female

Reported by a consumer/non-health professional from Germany on 2012-05-25

Patient: 62 year old female

Reactions: Intestinal Obstruction, Constipation

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: first infusion.
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-07-04

Cetuximab
    Dosage: most recent infusion 11-jul-05.
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-07-04

Vinorelbine
    Dosage: most recent infusion 11-jul-05.
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-07-04

Morphine
    Indication: Pain
    Start date: 2005-05-20



Possible Morphine side effects in 62 year old female

Reported by a consumer/non-health professional from Germany on 2012-05-18

Patient: 62 year old female

Reactions: Intestinal Obstruction, Constipation

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cetuximab
    Dosage: most recent infusion 11-jul-05.
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-07-04

Morphine
    Indication: Pain
    Start date: 2005-05-20

Cisplatin
    Dosage: first infusion.
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-07-04

Vinorelbine
    Dosage: most recent infusion 11-jul-05.
    Indication: non-Small Cell Lung Cancer
    Start date: 2005-07-04



Possible Morphine side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-14

Patient: male

Reactions: Flushing, Pruritus, Constipation

Drug(s) suspected as cause:
Morphine
    Dosage: 90 mg
    Administration route: Oral
    Indication: Back Pain

Morphine
    Dosage: 45 mg
    Administration route: Oral

Other drugs received by patient: Bezafibrate; M.v.i.; Lisinopril; Crestor; Fish OIL



Possible Morphine side effects in 64 year old female

Reported by a consumer/non-health professional from Brazil on 2012-04-30

Patient: 64 year old female, weighing 66.0 kg (145.2 pounds)

Reactions: Bedridden, Weight Decreased, Abdominal Pain, Buccal Mucosal Roughening, Tumour Pain, Bone Pain, Pain, Constipation, Drug Abuse, Feeling Cold, Abdominal Pain Upper, Malaise, Fatigue, Skin Discolouration, Nasal Dryness, Decreased Appetite, Aphthous Stomatitis, Blood Pressure Increased, Dyspnoea, Nail Discolouration, Nausea, Muscular Weakness, Convulsion, Tremor, Eating Disorder, Ageusia, Dysphonia, Blood Pressure Fluctuation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Buscopan Plus
    Dosage: unk
    Indication: Pain

Acetaminophen W / Codeine
    Dosage: unk
    Indication: Pain

Morphine
    Dosage: one tablet every 4 hours

Sutent
    Indication: Renal Cell Carcinoma

Acetaminophen
    Dosage: unk
    Indication: Pain

Morphine
    Dosage: a half of one tablet every 4 hours
    Indication: Pain

Sutent
    Dosage: 50 mg, 1x/day, 4 weeks on/2 weeks off
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2012-01-26

Sutent
    Indication: Metastases To Spine

Other drugs received by patient: Digesan; Buscopan Comp.; Rifaldin; Luftal; Phenytoin; Nystatin; Omeprazole; Vitamin E



Possible Morphine side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-11

Patient: male, weighing 70.3 kg (154.7 pounds)

Reactions: Pain, Rhinorrhoea, Gastric Disorder, Constipation, Ageusia, Balance Disorder, DRY Mouth, Anosmia, Memory Impairment

Drug(s) suspected as cause:
Morphine



Possible Morphine side effects in

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-03-20

Patient:

Reactions: Pruritus, Vomiting, Drug Ineffective, Nausea, Headache, Somnolence, Constipation, Delirium, Vertigo, Hallucination

Drug(s) suspected as cause:
Morphine
    Indication: Cancer Pain

Oxycodone HCL
    Indication: Cancer Pain

Fentanyl
    Indication: Cancer Pain

Hydromorphone HCL
    Administration route: Oral
    Indication: Cancer Pain



Possible Morphine side effects in 64 year old female

Reported by a consumer/non-health professional from Brazil on 2012-03-15

Patient: 64 year old female, weighing 66.0 kg (145.2 pounds)

Reactions: Weight Decreased, Bedridden, Abdominal Pain, Pain, Bone Pain, Tumour Pain, Constipation, Drug Abuse, Feeling Cold, Fatigue, Malaise, Decreased Appetite, Blood Pressure Increased, Aphthous Stomatitis, Dyspnoea, Nausea, Muscular Weakness, Tremor, Convulsion, Eating Disorder, Ageusia, Dysphonia, Blood Pressure Fluctuation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Acetaminophen W / Codeine
    Dosage: unk
    Indication: Pain

Morphine
    Dosage: one tablet every 4 hours

Buscopan Plus
    Dosage: unk
    Indication: Pain

Sutent
    Dosage: 50 mg, 1x/day, 4 weeks on/2 weeks off
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2012-01-26

Acetaminophen
    Dosage: unk
    Indication: Pain

Sutent
    Indication: Metastases To Spine

Morphine
    Dosage: a half of one tablet every 4 hours
    Indication: Pain

Other drugs received by patient: Nystatin; Omeprazole; Digesan; Rifaldin; Phenytoin; Vitamin E; Buscopan Comp.



Possible Morphine side effects in 45 year old female

Reported by a lawyer from United States on 2012-03-01

Patient: 45 year old female, weighing 81.6 kg (179.6 pounds)

Reactions: Diabetes Mellitus, Tachycardia, Pulmonary Embolism, Chronic Obstructive Pulmonary Disease, Hyperhidrosis, High Density Lipoprotein Decreased, Vaginal Haemorrhage, Pulmonary Arterial Pressure Increased, Product Taste Abnormal, Vulvovaginitis, Pneumonia, Pain in Extremity, Rhinitis, Ovarian Cyst, Acute Sinusitis, Narcolepsy, Dyslipidaemia, Chills, Restless Legs Syndrome, Pain, Impaired Work Ability, Pelvic Pain, Constipation, Suicidal Ideation, Lower Respiratory Tract Infection, Myalgia, Overdose, Fibromyalgia, Anger, Depression, Gastrooesophageal Reflux Disease, Condition Aggravated, Irregular Sleep Phase, Amnesia, Dysgeusia, Diarrhoea, Bipolar Disorder, Flank Pain

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Morphine
    Indication: Pain
    Start date: 2010-11-01
    End date: 2010-11-01

Seroquel XR
    Dosage: 300 mg;qpm;po, 400 mg;qpm;po
    Administration route: Oral
    Indication: Bipolar Disorder
    End date: 2010-09-01

Seroquel XR
    Dosage: 300 mg;qpm;po, 400 mg;qpm;po
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2010-11-01

Seroquel XR
    Dosage: 300 mg;qpm;po, 400 mg;qpm;po
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2010-09-01
    End date: 2010-11-01

Seroquel XR
    Dosage: 300 mg;qpm;po, 400 mg;qpm;po
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2010-09-01
    End date: 2010-09-01

Nuvaring
    Dosage: 1 df; vag
    Indication: Vaginal Haemorrhage
    Start date: 2010-09-11
    End date: 2010-11-03

Nuvaring
    Dosage: 1 df; vag
    Indication: Contraception
    Start date: 2010-09-11
    End date: 2010-11-03

Other drugs received by patient: Spiriva; Mirapex; Tramadol HCL; Magnesium; Lunesta; Tylenol W / Codeine; Fentanyl; Wellbutrin XL; Pristiq; Cortisporin; Asmanex Twisthaler; Niaspan; Potassium



Possible Morphine side effects in 56 year old female

Reported by a consumer/non-health professional from United States on 2012-02-27

Patient: 56 year old female

Reactions: Fatigue, Injection Site Haematoma, Constipation

Drug(s) suspected as cause:
Dilaudid

Victoza
    Dosage: unk, subcutaneous
    Indication: Type 2 Diabetes Mellitus

Morphine



Possible Morphine side effects in 56 year old male

Reported by a pharmacist from United States on 2012-02-15

Patient: 56 year old male, weighing 86.6 kg (190.5 pounds)

Reactions: Abdominal Pain, Dysuria, Condition Aggravated, Constipation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Morphine



Possible Morphine side effects in 23 year old female

Reported by a consumer/non-health professional from United States on 2012-02-03

Patient: 23 year old female, weighing 59.0 kg (129.7 pounds)

Reactions: Antiphospholipid Antibodies Positive, Constipation, Abortion Spontaneous, Superior Sagittal Sinus Thrombosis, Diplopia, Hypertrichosis, Pleural Effusion, Cerebral Thrombosis, Intracranial Venous Sinus Thrombosis, Electrocardiogram T Wave Inversion, Muscle Spasms, Visual Field Defect, Cerebral Venous Thrombosis, Maternal Exposure During Pregnancy, Hypercoagulation, Human Papilloma Virus Test Positive, Stress, Cerebrovascular Accident, Pneumonia Bacterial, NO Therapeutic Response

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Oxycontin
    Indication: Headache

Dilaudid
    Indication: Headache

Morphine
    Indication: Headache

Nuvaring
    Indication: Contraception
    Start date: 2007-01-01
    End date: 2007-09-01

Oxycodone HCL
    Indication: Headache



Possible Morphine side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-02

Patient: female, weighing 67.0 kg (147.4 pounds)

Reactions: Dyspnoea, Pneumonia, Hyperkalaemia, Anaemia, Pain, Pulmonary Embolism, Headache, Constipation, Disease Progression, Anxiety, Fatigue, Insomnia, Depression, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Erlotinib Hydrochloride
    Dosage: 150 mg, uid/qd
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer Stage IV
    Start date: 2011-10-04
    End date: 2011-11-21

Morphine
    Dosage: unk
    Administration route: Oral
    Indication: Lung Adenocarcinoma Stage IV

Dasatinib
    Dosage: 70 mg, uid/qd
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer Stage IV
    Start date: 2011-10-04
    End date: 2011-11-21

Other drugs received by patient: Ipratropium Bromide; MS Contin; Senna; Dexamethasone; Lactulose; Hydromorphone HCL; Albuterol; Enoxaparin; Famotidine; Magnesium Sulfate; Multi-Vitamin; Pepcid; Aluminium-Magnesium Hydroxide; Clindamycin; Dexamethasone Sodium Phosphate; Miralax; Ondansetron HCL; Ondansetron HCL; Senmosides Docustate Sodium; Reglan; Acetaminophen; Naloxone; Reglan; Remeron; Polyethylene Glycol; Mirtazapine



Possible Morphine side effects in 75 year old female

Reported by a physician from Uruguay on 2012-02-01

Patient: 75 year old female

Reactions: Abdominal Pain, Death, Dehydration, Electrolyte Imbalance, Blood Creatinine Increased, Constipation

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bisacodyl
    Dosage: 10 ml
    Indication: Constipation

Metoclopramide
    Dosage: 60 mg

Lactulose Solution Usp, 10 G / 15 ML
    Dosage: 40 ml
    Administration route: Oral
    Indication: Constipation

Morphine
    Dosage: 90 mg

Morphine
    Dosage: 280 mg
    Administration route: Oral
    Indication: Metastatic Pain

Dexamethasone
    Dosage: 16 mg
    Administration route: Oral
    Indication: Metastatic Pain

Neostigmine
    Indication: Constipation

Methadone HCL
    Dosage: 70 mg
    Administration route: Oral
    Indication: Metastatic Pain

Acetaminophen
    Dosage: 975 mg
    Administration route: Oral
    Indication: Metastatic Pain



Possible Morphine side effects in 71 year old male

Reported by a pharmacist from United States on 2012-01-30

Patient: 71 year old male, weighing 87.7 kg (192.9 pounds)

Reactions: Confusional State, Mental Status Changes, Myopia, Hallucination, Constipation, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Oxycodone HCL
    Dosage: 5 mg prn po
    Administration route: Oral
    Indication: Pain
    Start date: 2012-01-04
    End date: 2012-01-17

Morphine
    Dosage: 15 mg tid po
    Administration route: Oral
    Indication: Pain
    Start date: 2012-01-04
    End date: 2012-01-17



Possible Morphine side effects in 75 year old female

Reported by a health professional (non-physician/pharmacist) from Uruguay on 2012-01-20

Patient: 75 year old female

Reactions: Weight Decreased, Pain, Constipation, Abdominal Tenderness, Abdominal Discomfort, Death, Fatigue, Abdominal Distension, Electrolyte Imbalance, Blood Creatinine Increased, Decreased Appetite, Gastric Atony, Nausea, General Physical Health Deterioration, Cognitive Disorder, Ileus Paralytic, Dehydration, Gastrointestinal Disorder

Adverse event resulted in: death

Drug(s) suspected as cause:
Methadone HCL
    Dosage: 35 mg, qd
    Indication: Pain

Morphine
    Dosage: 280 mg, qd
    Indication: Pain

Morphine
    Dosage: 90 mg, qd

Methadone HCL
    Dosage: 70 mg, qd

Other drugs received by patient: Dexamethasone; Bisacodyl; Acetaminophen; Laxative



Possible Morphine side effects in 71 year old male

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-01-17

Patient: 71 year old male

Reactions: Drug Ineffective, Constipation

Drug(s) suspected as cause:
Morphine
    Dosage: 180 mg
    Administration route: Oral
    End date: 2011-04-01

Morphine
    Dosage: 240 mg
    Administration route: Oral
    Start date: 2011-04-01

Morphine
    Dosage: 20 mg
    Administration route: Oral
    Indication: Pain
    Start date: 2011-02-01
    End date: 2011-04-01

Morphine
    Dosage: 40 mg
    Administration route: Oral
    Start date: 2011-04-01

Morphine
    Dosage: 120 mg
    Administration route: Oral
    Indication: Breakthrough Pain
    Start date: 2011-02-01

Other drugs received by patient: Diclofenac; Pantoprazole; Amitriptyline HCL; Enemas; Lactulose; Alprazolam; Dexamethasone; Carbamazepine; Metoclopramide; Dexamethasone; Pamidronate Disodium; Carbamazepine; Pantoprazole



Possible Morphine side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-09

Patient: female, weighing 67.0 kg (147.4 pounds)

Reactions: Dyspnoea, Pneumonia, Hyperkalaemia, Anaemia, Pulmonary Embolism, Musculoskeletal Chest Pain, Headache, Constipation, Anxiety, Fatigue, Neoplasm Malignant, Insomnia, Depression, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Erlotinib Hydrochloride
    Dosage: 150 mg, uid/qd
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer Stage IV
    Start date: 2011-10-04
    End date: 2011-11-21

Morphine
    Dosage: unk
    Administration route: Oral
    Indication: Lung Adenocarcinoma Stage IV

Dasatinib
    Dosage: 70 mg, uid/qd
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer Stage IV
    Start date: 2011-10-04
    End date: 2011-11-21

Other drugs received by patient: Senna; Aluminium-Magnesium Hydroxide; Magnesium Sulfate; Dexamethasone; Reglan; Remeron; Acetaminophen; Albuterol; Enoxaparin; Ondansetron HCL; Mirtazapine; Multi-Vitamin; Ipratropium Bromide; Ondansetron HCL; Miralax; Pepcid; Lactulose; Reglan; Naloxone; Dexamethasone Sodium Phosphate; Famotidine; Polyethylene Glycol; Senmosides Docustate Sodium; Clindamycin; Hydromorphone HCL; MS Contin



Possible Morphine side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-21

Patient: female, weighing 67.0 kg (147.4 pounds)

Reactions: Pneumonia, Dyspnoea, Hyperkalaemia, Anaemia, Pulmonary Embolism, Musculoskeletal Chest Pain, Headache, Constipation, Anxiety, Fatigue, Neoplasm Malignant, Insomnia, Depression, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dasatinib
    Dosage: 70 mg, uid/qd
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer Stage IV
    Start date: 2011-10-04
    End date: 2011-11-21

Erlotinib Hydrochloride
    Dosage: 150 mg, uid/qd
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer Stage IV
    Start date: 2011-10-04
    End date: 2011-11-21

Morphine
    Dosage: unk
    Administration route: Oral
    Indication: Lung Adenocarcinoma Stage IV

Other drugs received by patient: Dexamethasone; Mirtazapine; Albuterol; Enoxaparin; MS Contin; Hydromorphone HCL; Miralax; Acetaminophen; Aluminium-Magnesium Hydroxide; Famotidine; Ipratropium Bromide; Multi-Vitamin; Pepcid; Ondansetron Hydrochloride; Ondansetron Hydrochloride; Lactulose; Remeron; Naloxone; Clindamycin; Senna; Magnesium Sulfate; Dexamethasone Sodium Phosphate; Polyethylene Glycol; Senmosides Docustate Sodium



Possible Morphine side effects in male

Reported by a health professional (non-physician/pharmacist) from South Africa on 2011-12-01

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: Abdominal Pain, Blood Albumin Decreased, Neoplasm Progression, Platelet Count Increased, Pyrexia, Constipation, RED Cell Distribution Width Increased, Haematocrit Decreased, C-Reactive Protein Increased, RED Blood Cell Count Decreased, Unevaluable Event, Blood Sodium Decreased, Decreased Appetite, White Blood Cell Count Increased, Back Pain, Vomiting, Neutrophil Count Increased, Nausea, Blood Chloride Decreased, Intestinal Obstruction, Gastrointestinal Stromal Tumour, Monocyte Count Increased, Hypercalcaemia, Haemoglobin Decreased, Small Intestinal Obstruction, Neoplasm Malignant, Hypophagia, NO Therapeutic Response, Mean Cell Haemoglobin Decreased, RED Blood Cell Sedimentation Rate Increased, Inflammation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tasigna
    Dosage: 400 mg, bid
    Administration route: Oral
    Indication: Gastrointestinal Stromal Tumour
    Start date: 2010-10-13
    End date: 2010-10-14

Zafor
    Dosage: 400 mg, prn
    Administration route: Oral
    Indication: Nausea
    Start date: 2010-10-17
    End date: 2010-10-26

Tasigna
    Dosage: 400 mg, qd

Tasigna
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2010-11-19
    End date: 2011-04-11

Imatinib Mesylate
    Dosage: 400 mg, daily
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-11-02

Duragesic-100
    Dosage: unk

Tasigna
    Dosage: 400 mg, bid
    Administration route: Oral
    End date: 2010-11-01

Morphine
    Dosage: unk

Imatinib Mesylate
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Gastrointestinal Stromal Tumour
    Start date: 2011-04-16
    End date: 2011-04-17

Lentogesic
    Dosage: unk
    Administration route: Oral
    Indication: Pain
    Start date: 2010-10-12
    End date: 2010-10-26

Other drugs received by patient: Iron Supplements; Calcium; Omeprazole; Sucralfate; Rabeprazole Sodium



Possible Morphine side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-30

Patient: female, weighing 67.0 kg (147.4 pounds)

Reactions: Pneumonia, Hyperkalaemia, Anaemia, Pulmonary Embolism, Musculoskeletal Chest Pain, Headache, Constipation, Anxiety, Fatigue, Neoplasm Malignant, Insomnia, Depression, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Erlotinib Hydrochloride
    Dosage: 150 mg, uid/qd
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer Stage IV
    Start date: 2011-10-04
    End date: 2011-11-21

Dasatinib
    Dosage: 70 mg, uid/qd
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer Stage IV
    Start date: 2011-10-04
    End date: 2011-11-21

Morphine
    Dosage: unk
    Administration route: Oral
    Indication: Lung Adenocarcinoma Stage IV

Other drugs received by patient: Hydromorphone HCL; Mirtazapine; Senna; Senmosides Docustate Sodium; Dexamethasone Sodium Phosphate; Famotidine; Ondansetron Hydrochloride; Lactulose; Acetaminophen; Enoxaparin; Naloxone; Polyethylene Glycol; Clindamycin; Pepcid; Ipratropium Bromide; Ondansetron Hydrochloride; Miralax; Aluminium-Magnesium Hydroxide; Dexamethasone; Multi-Vitamin; Remeron; Albuterol; Magnesium Sulfate



Possible Morphine side effects in 63 year old female

Reported by a consumer/non-health professional from United States on 2011-11-11

Patient: 63 year old female

Reactions: Pruritus, Oedema, Hyperhidrosis, Constipation, Muscle Rigidity

Drug(s) suspected as cause:
Morphine

Other drugs received by patient: Vitamin D



Possible Morphine side effects in male

Reported by a consumer/non-health professional from South Africa on 2011-11-09

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: Abdominal Pain, Vomiting, Nausea, Neoplasm Malignant, Hypophagia, Intestinal Obstruction, Pyrexia, Constipation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Tasigna
    Dosage: 400 mg, bid
    Administration route: Oral
    Indication: Gastrointestinal Stromal Tumour
    Start date: 2010-10-13
    End date: 2010-10-14

Imatinib Mesylate
    Dosage: 400 mg, daily
    Administration route: Oral
    Start date: 2011-04-21

Morphine
    Dosage: unk

Tasigna
    Dosage: 400 mg, bid
    Administration route: Oral
    End date: 2010-11-01

Zafor
    Dosage: 400 mg, prn
    Administration route: Oral
    Indication: Nausea
    Start date: 2010-10-17
    End date: 2010-10-26

Lentogesic
    Dosage: unk
    Administration route: Oral
    Indication: Pain
    Start date: 2010-10-12
    End date: 2010-10-26

Duragesic-100
    Dosage: unk

Tasigna
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2010-11-19
    End date: 2011-04-11

Tasigna
    Dosage: 400 mg, qd

Imatinib Mesylate
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Gastrointestinal Stromal Tumour
    Start date: 2011-04-16
    End date: 2011-04-17

Other drugs received by patient: Rabeprazole Sodium; Calcium; Sucralfate; Iron Supplements; Omeprazole



Possible Morphine side effects in 69 year old male

Reported by a pharmacist from United States on 2011-10-26

Patient: 69 year old male, weighing 115.5 kg (254.1 pounds)

Reactions: Constipation, Treatment Noncompliance

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Morphine



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012